John A. Ward

Array ( [id] => 530076 [patent_doc_number] => 07179650 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-20 [patent_title] => 'Compositions and uses for a novel cell-death-protecting protein' [patent_app_type] => utility [patent_app_number] => 09/484964 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 29128 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179650.pdf [firstpage_image] =>[orig_patent_app_number] => 09484964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383738 [patent_doc_number] => 06544506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'Veto cells effective in preventing graft rejection and devoid of graft versus host potential' [patent_app_type] => B2 [patent_app_number] => 09/477737 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 12410 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544506.pdf [firstpage_image] =>[orig_patent_app_number] => 09477737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235473 [patent_doc_number] => 06689605 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Controlling immune response to specific antigens' [patent_app_type] => B1 [patent_app_number] => 09/424281 [patent_app_country] => US [patent_app_date] => 2000-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 31 [patent_no_of_words] => 14418 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689605.pdf [firstpage_image] =>[orig_patent_app_number] => 09424281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887921 [patent_doc_number] => 20020012660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'METHOD OF PREPARING A SOMATIC CELLS FOR NUCLEAR TRANSFER' [patent_app_type] => new [patent_app_number] => 09/475674 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21547 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012660.pdf [firstpage_image] =>[orig_patent_app_number] => 09475674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1335586 [patent_doc_number] => 06596924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents' [patent_app_type] => B1 [patent_app_number] => 09/465666 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 11719 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596924.pdf [firstpage_image] =>[orig_patent_app_number] => 09465666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567776 [patent_doc_number] => 20020165172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES' [patent_app_type] => new [patent_app_number] => 09/466035 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35664 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165172.pdf [firstpage_image] =>[orig_patent_app_number] => 09466035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 474301 [patent_doc_number] => 07226589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor' [patent_app_type] => utility [patent_app_number] => 09/458610 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9746 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226589.pdf [firstpage_image] =>[orig_patent_app_number] => 09458610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370221 [patent_doc_number] => 06558663 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Transgenic swine & swine cells having human HLA genes' [patent_app_type] => B1 [patent_app_number] => 09/457177 [patent_app_country] => US [patent_app_date] => 1999-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 27150 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558663.pdf [firstpage_image] =>[orig_patent_app_number] => 09457177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4325635 [patent_doc_number] => 06319709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Tumor cells with increased immunogenicity and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/450798 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 8 [patent_no_of_words] => 18282 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319709.pdf [firstpage_image] =>[orig_patent_app_number] => 450798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1593964 [patent_doc_number] => 06491908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Selective elimination of T cells that recognize specific preselected targets' [patent_app_type] => B1 [patent_app_number] => 09/435321 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20500 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491908.pdf [firstpage_image] =>[orig_patent_app_number] => 09435321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478771 [patent_doc_number] => 07223739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Adjuvanted genetic vaccines' [patent_app_type] => utility [patent_app_number] => 09/433777 [patent_app_country] => US [patent_app_date] => 1999-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17297 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223739.pdf [firstpage_image] =>[orig_patent_app_number] => 09433777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1339242 [patent_doc_number] => 06589782 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Angiogenic factor and use thereof in treating cardiovascular disease' [patent_app_type] => B1 [patent_app_number] => 09/428909 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 18331 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589782.pdf [firstpage_image] =>[orig_patent_app_number] => 09428909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240743 [patent_doc_number] => 06682729 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same' [patent_app_type] => B1 [patent_app_number] => 09/420770 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14249 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682729.pdf [firstpage_image] =>[orig_patent_app_number] => 09420770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346108 [patent_doc_number] => 06284742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Immunomodulation by genetic modification of dendritic cells and B cells' [patent_app_type] => 1 [patent_app_number] => 9/407511 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9918 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284742.pdf [firstpage_image] =>[orig_patent_app_number] => 407511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674832 [patent_doc_number] => 20030060435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'METHOD OF CANCER TREATMENT BY P53 PROTEIN CONTROL' [patent_app_type] => new [patent_app_number] => 09/405920 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5521 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060435.pdf [firstpage_image] =>[orig_patent_app_number] => 09405920 [rel_patent_id] =>[rel_patent_doc_number] =>)